Methods and systems for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia of a patient

• US 8,721,584 B2
• Filed: 11/02/2007
• Issued: 05/13/2014
• Est. Priority Date: 11/02/2006
• Status: Expired due to Fees

• Current Assignee: Emory University, University of South Carolina
• Original Assignee: Emory University, University of North Carolina At Chapel Hill (University of North Carolina System)
• Inventors: Braithwaite, Susan S., Umpierrez, Guillermo E.
• Primary Examiner(s): Lucchesi, Nicholas
• Assistant Examiner(s): CHANDER, DIVA KAKAR
• Application Number:
  US12/513,426
• Publication Number:
  US 20100137788A1
• Time in Patent Office: 2,384 Days
• Field of Search: 604/66
• US Class Current: 604/66
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2005/14296 Pharmacokinetic models
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

Methods and systems for determining an intravenous infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia are disclosed. In one aspect, a method for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient includes estimating an insulin infusion maintenance rate to maintain euglycemia in a patient. Further, a relationship between a current blood glucose concentration of the patient and a target blood glucose concentration may be determined. An insulin infusion rate may be determined based on the estimated insulin infusion maintenance rate and based on the relationship between the current blood glucose concentration and the target blood glucose concentration. A glycemic response of the patient may be measured while using the determined insulin infusion rate. The insulin infusion maintenance rate is re-estimated based on the glycemic response of the patient at a previous insulin infusion rate.

Claims

1. A system for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, the system comprising:

(a) a measurement receiver configured to receive a glycemic measurement of a patient; and

(b) an insulin infusion rate calculator configured to;

(i) estimate a maintenance rate (MR) of insulin infusion to maintain euglycemia in the patient;

(ii) determine a relationship between a current blood glucose concentration of the patient and a target blood glucose concentration;

(iii) determine an MR-dependent insulin infusion rate (IR) based on the estimated MR and based on the relationship between the current blood glucose concentration and the target blood glucose concentration, wherein determining the MR-dependent IR includes assigning the patient to an iso-MR function that defines a relationship between IR values and blood glucose concentrations based on distance from target, and which during hyperglycemia is based on an ideal rate of descent of blood glucose concentration;

(iv) measure a glycemic response of the patient while using the determined IR;

(v) re-estimate the MR based on the glycemic response of the patient at a previous IR; and

(vi) repeatedly perform steps (ii)-(v), wherein the estimated MR in step (v) during each n^th iteration is utilized to determine the IR in step (iii) of each (n+1)^th iteration, n being an integer.

2. The system of claim 1 wherein the insulin infusion rate calculator is configured to identify the iso-MR function from a plurality of iso-MR functions that provides the IR as a function of blood glucose concentration, wherein the functions are each associated with different MR values.

3. The system of claim 2 wherein the insulin infusion rate calculator is configured to receive input regarding the patient condition of the patient, and configured to enter predetermined parameter values, based on a condition of the patient, that will identify a family of functions for a next IR for the patient such that the functions differ within the family according to the MR, wherein the members of a family of functions are the same with respect to target blood glucose concentrations (BG_{upper target}, BG_{true target}, and BG_{lower target}), BG_{critical high}, IR_@BG70, ROD_{@BGcritical high}, and ROD_{ideal,next,max}.

4. The system of claim 3 wherein one of the families is associated with general hospital care;

one of the families diabetic ketoacidosis, and wherein one of the families is associated with hyperglycemic hyperosmolar state.

5. The system of claim 1 wherein the insulin infusion rate calculator is configured to estimate the MR using the following equation during hyperglycemia:

6. The system of claim 1 wherein at least functions (i), (ii), (iv), (v), and (vi) are automated.

7. A system for determining an intravenous insulin infusion rate to maintain euglycemia of a patient, the system comprising:

(a) a measurement receiver configured to receive a glycemic measurement of a patient; and

(b) an insulin infusion rate calculator configured to;

(i) estimate a maintenance rate (MR) of insulin infusion to maintain euglycemia in the patient;

(ii) determine a relationship between a current blood glucose concentration of the patient and a target blood glucose concentration;

(iii) determine an MR-dependent insulin infusion rate (IR) based on the estimated maintenance rate, wherein determining the MR-dependent IR includes assigning the patient to an iso-MR function that defines a relationship between IR values and blood glucose concentrations based on distance of blood glucose from target and, in case of hyperglycemia, based on an ideal rate of descent of blood glucose concentration;

(iii) measure a glycemic response of the patient to an insulin infusion given to the patient using the determined IR;

(iv) re-estimate the MR based on the glycemic response of the patient; and

(v) repeatedly perform functions (ii)-(iv), wherein the estimated MR in function (iv) during each n^th iteration is utilized to calculate the IR in function (ii) of each (n+1)^th iteration, n being an integer.